SFCM
UTHR icon

Seven Fleet Capital Management’s United Therapeutics UTHR Stock Holding History

Seven Fleet Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$669K Sell
1,128
-172
-13% -$85.7K 0.21% 73
2025
Q4 		$633K Buy
+1,300
New +$605K 0.43% 43

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Seven Fleet Capital Management's UTHR Position: Q1 2026 in Review

Seven Fleet Capital Management reduced its United Therapeutics (UTHR) stake by 13% in Q1 2026, selling an estimated $85.7K and leaving 1,128 shares worth $669K. The position accounts for 0.21% of the portfolio, ranked #73.

Seven Fleet Capital Management first reported a position in UTHR in Q4 2025 and has held it in 2 quarters since. 852 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Seven Fleet Capital Management held 1,128 shares of United Therapeutics worth $669K as of Q1 2026.
  • Seven Fleet Capital Management sold 172 United Therapeutics shares in Q1 2026, an estimated $85.7K.
  • United Therapeutics made up 0.21% of Seven Fleet Capital Management's portfolio in Q1 2026, its #73 holding.
  • Seven Fleet Capital Management first reported a position in United Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 852 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.